Aromasin
Aromasin

3.56
For patients managing oncology care, this generic medicine inhibits the conversion of androgens to estrogens, reducing hormonal support for specific cell growth.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Exemestane
Reference Brand
Exemestane
Product Origin
Generic Alternative
Reference Manufacturer
Pfizer
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Hormones
Product Category
Steroidal Aromatase Inhibitor
Pharmacological Class
Aromatase Inhibitor
Clinical Indications
Manufacturer Description
Utilized to manage hormone responsive tumors to alleviate growth pathways and support endocrine maintenance protocols.
Mechanism of Action
Irreversibly binds to and inactivates the aromatase enzyme, causing sub-detectable estrogen levels in postmenopausal women.
Route of Administration
Oral
Onset Time
2–4 weeks
Duration
24 hours
Contraindications
Pregnancy, Premenopausal status, Hypersensitivity to exemestane
Severe Adverse Events
Anaphylaxis — requires immediate medical attention, Severe osteoporosis — requires immediate medical attention
Common Side Effects
Hot flashes, Fatigue, Joint pain
Uncommon Side Effects
Increased sweating, Insomnia, Nausea
Drug Interactions
Rifampin, St. John's Wort, Estrogen-containing medications
Pregnancy Safety Warnings
TGA Category X: Strictly contraindicated due to fetal toxicity. Breastfeeding: Do not use.
Age Restrictions
Approved for postmenopausal females.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Aromasin is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to purchase PE & ED Medication - Vardenafil Dapoxetine PE ED Combination